CBU
DGX icon

CIBC Bancorp USA’s Quest Diagnostics DGX Stock Holding History

CIBC Bancorp USA’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.64M Sell
31,355
-8,406
-21% -$1.65M 0.01% 659
2026
Q1 		$7.79M Buy
+39,761
New +$7.73M 0.01% 584
2025
Q3 		$3.28M Buy
+17,190
New +$3.05M 0.02% 492

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

CIBC Bancorp USA's DGX Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Quest Diagnostics (DGX) stake by 21% in Q2 2026, selling an estimated $1.65M and leaving 31,355 shares worth $6.64M. The position accounts for 0.01% of the portfolio, ranked #659.

CIBC Bancorp USA first reported a position in DGX in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.79M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • CIBC Bancorp USA held 31,355 shares of Quest Diagnostics worth $6.64M as of Q2 2026.
  • CIBC Bancorp USA sold 8,406 Quest Diagnostics shares in Q2 2026, an estimated $1.65M.
  • Quest Diagnostics made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #659 holding.
  • CIBC Bancorp USA first reported a position in Quest Diagnostics in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Quest Diagnostics position peaked at $7.79M in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.